You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
More Efficient GaN- SiGe based MMICs for Communication and Radar Systems
SBC: EPISENSORS INC Topic: N14AT007Active Electronic Scanned Array (AESA) radars play a strategic role in surveillance and reconnaissance. A GaN based T/R circuit will be radiation-hard but difficult to integrate with the remainder of the signal chain due to incompatible technologies. SiGe HBT technology, with its high frequency performance and the ability to blend in with CMOS, can act as a bridge between the high frequency III-V ...
STTR Phase I 2014 Department of DefenseNavy -
Microbial Surrogate Assay for Environmental PAH Exposure
SBC: ARPHION LTD Topic: NIEHSDESCRIPTION (provided by applicant): Arphion is a company established to develop noninvasive products that will be used to diagnose, prevent, and treat head and neck and other cancers. 41,000 people are diagnosed with head and neck cancer (HNC) every yearin the United States, with 8,000 deaths. Tens of millions of people in the US are at increased risk for HNC due to exposure to the polycyclic ary ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Hepatitis C Virus RNA-Targeted Therapeutics
SBC: VIOGEN BIOSCIENCES, LLC Topic: NIAIDDESCRIPTION (provided by applicant): Hepatitis C virus (HCV) infection is a significant human health issue, accounting for 50% of liver transplants in the US, with approximately 170 million persons infected worldwide. The current standard of care therapy of PEGylated-interferon and ribavirin is effective in only about 50% of patients, with severe side effects and contraindications limiting patient ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Topically-delivered Targeted Gene Suppression of Immune Activation in Psoriasis
SBC: Exicure, Inc. Topic: NIAMSDESCRIPTION (provided by applicant): AuraSense Therapeutics (AST), along with Northwestern University, is applying a recently developed technology using oligonucleotide-functionalized nanoparticles (called spherical nucleic acids or SNAs) to control protein expression. These easily synthesized nanoparticles can have either DNA or RNA shells, and are less than 50 nm in hydrodynamic diameter. SNA co ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Ultra-Lightweight, High-Efficiency Epitaxial Lift-Off Solar Cells and Arrays
SBC: MICROLINK DEVICES INC Topic: N14AT003MicroLink Devices and the University of Notre Dame propose to develop an ultra-lightweight, high-efficiency, GaAs-based, multi-junction solar cell that will be suitable for use in future platforms requiring very high specific power (>3.0 kW/kg) and very high areal power density (>370 W/m2). We will achieve this result by reducing the metal content of MicroLinks current inverted metamorphic (IMM), ...
STTR Phase I 2014 Department of DefenseNavy -
Development of Characterization of Failure Modes for Mechanical Components
SBC: Thornton Tomasetti, Inc. Topic: N14AT011This proposal describes a new process to facilitate the shock qualification of submarine components, taking advantage of the similarities between readily observable design features of these components, and correlating them to success or failure in Navy shock qualification tests. To realize this Design Feature Similarity (DFS) approach, we will develop a set of criteria based on this type of readil ...
STTR Phase I 2014 Department of DefenseNavy -
POC 2-D Diffusion Assay for self-monitoring of BNP
SBC: SENTILUS Topic: NHLBIDESCRIPTION (provided by applicant): The objective of this STTR proposal is to develop a 2-D diffusion point-of-care assay (POC) for B-type natriuretic peptide (BNP). The primary goal of the proposed work is to create a test format that will allow patientswith chronic heart failure to quantitatively self-monitor serum levels of BNP. Determination of baseline level of BNP and changes in this level ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Science Take-Out Kits for Environmental Health Education
SBC: Science Take-Out, LLC Topic: NIEHSDESCRIPTION provided by applicant Nearly percent of death and disease worldwide is linked to environmental factors WHO therefore it is critical that the general public has basic understanding of how the environment affects their health and how they might protect themselves against environmental exposures Unfortunately environmental health content is typically covered on a very ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
A Millimeter-wave Tunable Cavity for Ultra-sensitive Solids and Liquids DNP-NMR at Low Budget
SBC: DOTY SCIENTIFIC, INC. Topic: NIA? DESCRIPTION (provided by applicant): NMR is probably the most powerful and widely used analytical technique for structure determination and function elucidation of molecules of all types, but it suffers from low sensitivity, particularly for insoluble biological macromolecules. Dynamic Nuclear Polarization (DNP) with Magic Angle Spinning (MAS) has recently demonstrated S/N gains exceeding t ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
New generation of catheters for treatment of atrial fibrillation
SBC: NOCTURNAL PRODUCT DEVELOPMENT, LLC Topic: NHLBIDESCRIPTION (provided by applicant): Atrial fibrillation remains the most commonly occurring cardiac arrhythmia. It is associated with a lower quality of life and a higher rate of morbidity and mortality. Cryotherapy and radiofrequency catheter ablations for the purpose of eliminating atrial fibrillation have become a mainstream treatment option. They produce lesions that block the spread of elect ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health